HanchorBio (漢康生技) is developing a technology for the creation of next generation personalized biotherapeutics. Based in San Francisco, Taipei, and Shanghai, we are led by a group of pharmaceutical industry veterans with proven track-record of success is biologics discovery and global development with bold vision to rewrite immunotherapies.
Committed to reactivating the immune system to fight against diseases, our proprietary Fc-based designer biologics (FBDB™) platform enables unique biologics with diverse multi-targeting modalities to unleash both innate and adaptive immunity to help revolutionize the treatment of people with cancer and other debilitating diseases. Our FBDB™ platform has successfully delivered proof-of-concept data in several in-vivo animal models. By making breakthroughs in multi-functional innovative molecular configurations in R&D and improving the manufacturing methodology in CMC, we develop transformative medicines to address unmet medical needs.
Company Details
- Employees
- 37
- Founded
- 2020
- Address
- 5f-1, No.1, Sec. 1, Tiding Blvd.,, Taipei,neihu District 114,taiwan, Province Of China
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.hanchorbio.com
- Keywords
- Immunotherapy and Fc-fusion protein.
- HQ
- Taipei, Neihu District
Hanchorbio Inc. 漢康生技股份有限公司 Questions
Hanchorbio Inc. 漢康生技股份有限公司's website is https://www.hanchorbio.com
Hanchorbio Inc. 漢康生技股份有限公司's LinkedIn profile is https://www.linkedin.com/company/hanchorbio-inc
Hanchorbio Inc. 漢康生技股份有限公司 has
37 employees.
View email and phone details for 37
employees at Hanchorbio Inc. 漢康生技股份有限公司.
Hanchorbio Inc. 漢康生技股份有限公司's industry is
Biotechnology Research
Hanchorbio Inc. 漢康生技股份有限公司's top competitors are
Sartorius,
Staidson Biopharma Inc,
Taimed Biologics,
Southern Rna 🧬,
Geneonline,
Global Bio & Investment Monthly,
Glyconex Inc.,
Huidagene Therapeutics,
Pharmaessentia,
Henlius.
Hanchorbio Inc. 漢康生技股份有限公司's categories are Biotechnology Research
Hanchorbio Inc. 漢康生技股份有限公司's founding year is 2020
